相关实验视频

Updated: May 5, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

在成年人中对AdCLD-CoV19-1疫苗进行剂量依赖的血清分析

Jung Hyuk Lee^1,2, Yuna Shin¹, Kwang-Soo Shin³

¹International Vaccine Institute, Seoul, South Korea.

|December 26, 2024

概括

这是AdCLD-CoV19-1疫苗.

科学领域:

免疫学免疫学免疫学
疫苗学疫苗学疫苗学
病毒学病毒学

背景情况:

基于化学腺病毒的严重急性呼吸综合征冠状病毒2 (SARS-CoV-2) 疫苗旨在引起强大的免疫反应.
了解剂量依赖性幽默免疫对于优化疫苗疗效至关重要.
非中和抗体和Fc介导的效应因子功能有助于对SARS-CoV-2的保护.

研究的目的:

用系统血清学研究AdCLD-CoV19-1疫苗诱导的幽默性免疫反应的剂量依赖性变化.
分析抗体特征,Fc受体结合和效应器功能,以应对低剂量和高剂量的疫苗.
评估疫苗剂量对对SARS-CoV-2尖端蛋白域和变体的反应的影响.

主要方法:

一期临床试验分析了接受低剂量或高剂量的AdCLD-CoV19-1疫苗的参与者的血清样本.
对SARS-CoV-2尖峰 (S) 域 (全长S,S1,S2,受体结合域) 的抗体特征的系统血清学分析.
对Fc受体结合,FcγR2A和FcγR3B相互作用以及抗体依赖性中性粒细胞化 (ADNP) 与原型和Omicron BA.2变异的评估.

主要成果:

低剂量和高剂量AdCLD-CoV19-1疫苗都诱导了强大的幽默反应,并观察到质量差异.
高剂量组显示出显著更高的S2特异性抗体水平,增强的Fc受体结合 (FcγR2A,FcγR3B) 和更强的ADNP.
高剂量疫苗接种维持了优异的S2特异性IgG和FcγR3B结合,以及对Omicron BA.2变种的ADNP升高.

结论:

疫苗剂量显著影响针对SARS-CoV-2的幽默性免疫反应的质量和功能,特别是针对S2特异性抗体.
较高的疫苗剂量增强了Fc介导的效应因子功能,如ADNP,这可能有助于改善保护.
系统血清学通过评估各种抗体特征,为优化基于腺病毒载体的疫苗剂量策略提供了宝贵的见解.

关键词:

这就是SARS-CoV-2病毒.基于腺病毒载体的疫苗效应器的功能是效应器的功能.尖子蛋白质是什么?系统血清学血清学

更多相关视频

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

相关概念视频

Enzyme-Linked Immunosorbent Assay

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...

Dose-Response Relationship: Potency and Efficacy

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...